Nomfarm Noocholine solution 250mg/ml 4ml ampoules, 3pcs

Composition

Active ingredient:

choline alfoscerate 250 mg;

Auxiliary substance:

water

Pharmacological action

Noocholine Rompharm is a nootropic drug, a central cholinomimetic with a predominant effect on the central nervous system. The drug contains 40.5% metabolically protected choline. Choline alfoscerate in the body under the influence of brain enzymes, is broken down into choline and glycerophosphate. Choline is involved in the synthesis of acetylcholine, transmitting nerve impulses and improving brain function, and glycerophosphate is a precursor of phosphatidylcholine in neuronal membranes.

Choline alfoscerate improves cerebral blood flow, enhances metabolic processes in the brain, activates the structures of the reticular formation of the brain and restores consciousness in traumatic brain injury.

The results of clinical studies have shown that choline alfoscerate stimulates the dose-dependent release of acetylcholine under physiological conditions of neurotransmission.

Pharmacokinetics

Distribution

Easily penetrates various tissues and organs, including the brain.

Deduction

It is mainly excreted by the lungs in the form of carbon dioxide (85%), and is also excreted by the kidneys and through the intestines (15%).

Indications

• acute period of craniocerebral trauma with a predominantly stem level of damage;
• psycho-organic syndrome against the background of degenerative and involutional changes in the brain;
• consequences of cerebrovascular insufficiency (impaired thinking function);
• multi-infarction dementia.

Use during pregnancy and lactation

The use of the drug during pregnancy and lactation is contraindicated.

Breast-feeding should be discontinued for the duration of treatment.

The drug does not have teratogenic and mutagenic effects.

Contraindications

Hemorrhagic stroke (acute stage); hypersensitivity to the components of the drug.

Side effects

From the digestive system:  constipation, diarrhea, dryness of the oral mucosa, pharyngitis.

Nervous system disorders:  headache, drowsiness, insomnia, aggressiveness, anxiety, nervousness, brain ischemia, dizziness.

From the side of the skin:  rash, urticaria.

Other services:  pain at the injection site, increased urination.

How to take, course of use and dosage

In acute conditions-IV or iv (slowly),1 g per day for 15-20 days; then switch to oral use of 0.8 g in the morning and 0.4 g in the afternoon for 6 months.

Overdose

Symptoms:  in case of overdose, nausea is noted, which passes after reducing the dose or stopping treatment.

Treatment:  conducting symptomatic therapy.

Form of production

Solution for intravenous and intramuscular use

Storage conditions

In a dark place, at a temperature of 15 °C.

Shelf life

2 years

Active ingredient

Choline alfoscerate

Conditions of release from pharmacies

By prescription

Dosage form

solution for injection and infusion

Description

For adults as directed by your doctor

Indications

Alzheimer’s Disease, Acquired Dementia, Mental Disorders, Stroke Effects, Cerebral Circulation Disorders